These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14627686)

  • 1. Association of INPP1, PIK3CG, and TSC2 gene variants with autistic disorder: implications for phosphatidylinositol signalling in autism.
    Serajee FJ; Nabi R; Zhong H; Mahbubul Huq AH
    J Med Genet; 2003 Nov; 40(11):e119. PubMed ID: 14627686
    [No Abstract]   [Full Text] [Related]  

  • 2. Leading-edge research: PtdIns(3,4,5)P3 and directed migration.
    Franca-Koh J; Kamimura Y; Devreotes PN
    Nat Cell Biol; 2007 Jan; 9(1):15-7. PubMed ID: 17199126
    [No Abstract]   [Full Text] [Related]  

  • 3. Signalling through phosphoinositide 3-kinases: the lipids take centre stage.
    Leevers SJ; Vanhaesebroeck B; Waterfield MD
    Curr Opin Cell Biol; 1999 Apr; 11(2):219-25. PubMed ID: 10209156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoinositide signaling in urological disease.
    Theodorescu D
    J Urol; 2003 Jun; 169(6):2394-6. PubMed ID: 12771804
    [No Abstract]   [Full Text] [Related]  

  • 5. [Involvement of phosphoinositide 3-kinases and phosphoinositide phosphatases in immune responses, glucose metabolism and tumorigenesis].
    Sasaki T; Sasaki J; Suzuki A; Penninger JM
    Tanpakushitsu Kakusan Koso; 2001 Sep; 46(12):1820-9. PubMed ID: 11552264
    [No Abstract]   [Full Text] [Related]  

  • 6. Phosphatidylinositol 3-kinase, phosphoinositides and apoptosis. Polyphosphoinositol phosphatase and apoptosis.
    Sarmay G
    Subcell Biochem; 2002; 36():309-33. PubMed ID: 12037988
    [No Abstract]   [Full Text] [Related]  

  • 7. High-throughput sequencing of mGluR signaling pathway genes reveals enrichment of rare variants in autism.
    Kelleher RJ; Geigenmüller U; Hovhannisyan H; Trautman E; Pinard R; Rathmell B; Carpenter R; Margulies D
    PLoS One; 2012; 7(4):e35003. PubMed ID: 22558107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Receptor tyrosine kinases (c-kit, c-fmns, Flt-3, Tie2, etc.)].
    Yoshimura A; Sanada M; Mashima R
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():207-14. PubMed ID: 15861658
    [No Abstract]   [Full Text] [Related]  

  • 9. Phosphatidylinositol signalling reactions.
    Zhang X; Majerus PW
    Semin Cell Dev Biol; 1998 Apr; 9(2):153-60. PubMed ID: 9599410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytokine receptors and signal transduction].
    Nakajima H; Kitamura T
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():178-86. PubMed ID: 15861654
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease.
    Oudit GY; Sun H; Kerfant BG; Crackower MA; Penninger JM; Backx PH
    J Mol Cell Cardiol; 2004 Aug; 37(2):449-71. PubMed ID: 15276015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic abnormalities in endometrial cancer].
    Takeshima N; Hirai Y
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():254-8. PubMed ID: 15535246
    [No Abstract]   [Full Text] [Related]  

  • 13. SNP identification, haplotype analysis, and parental origin of mutations in TSC2.
    Roberts PS; Chung J; Jozwiak S; Dabora SL; Franz DN; Thiele EA; Kwiatkowski DJ
    Hum Genet; 2002 Jul; 111(1):96-101. PubMed ID: 12136241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of tryptophan 2,3 dioxygenase gene polymorphism with autism.
    Nabi R; Serajee FJ; Chugani DC; Zhong H; Huq AH
    Am J Med Genet B Neuropsychiatr Genet; 2004 Feb; 125B(1):63-8. PubMed ID: 14755447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Topics on gene abnormality in endometrial cancer].
    Shiozawa T; Konishi I
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():259-63. PubMed ID: 15535247
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression.
    Ma L; Teruya-Feldstein J; Behrendt N; Chen Z; Noda T; Hino O; Cordon-Cardo C; Pandolfi PP
    Genes Dev; 2005 Aug; 19(15):1779-86. PubMed ID: 16027168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2.
    Manning BD; Logsdon MN; Lipovsky AI; Abbott D; Kwiatkowski DJ; Cantley LC
    Genes Dev; 2005 Aug; 19(15):1773-8. PubMed ID: 16027169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling.
    Paez J; Sellers WR
    Cancer Treat Res; 2003; 115():145-67. PubMed ID: 12613196
    [No Abstract]   [Full Text] [Related]  

  • 19. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.
    Zhong H; Chiles K; Feldser D; Laughner E; Hanrahan C; Georgescu MM; Simons JW; Semenza GL
    Cancer Res; 2000 Mar; 60(6):1541-5. PubMed ID: 10749120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association between autism and SLC25A12.
    Rabionet R; McCauley JL; Jaworski JM; Ashley-Koch AE; Martin ER; Sutcliffe JS; Haines JL; DeLong GR; Abramson RK; Wright HH; Cuccaro ML; Gilbert JR; Pericak-Vance MA
    Am J Psychiatry; 2006 May; 163(5):929-31. PubMed ID: 16648338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.